6744 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Feng Chi Biotech Corp. engages in the provision of neonatal genetic disease testing, new born screening, life science and microbiological testing services. It focuses on colorectal cancer, lung cancer; scientific research genetic testing and development. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6744 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company